Organoid Sciences, a biotech company that specializes in organ analog models (or organoids), held a webinar for the first time, opening a new chapter of its new drug development program. Organoid Sciences hosted a webinar on “an organoid-based platform that boosts chances of success of new drug development” online on the 29th of October.

At this webinar, Ji Hyo Kim, head of the new drug development team, gave a lecture under the topic of “the introduction of an organoid-based evaluation model.” She introduced the usage of organoids and the need for a clinical prediction models during the development process of new drugs.

Organoid Sciences is being recognized for its unique technology in organoid-based regenerative treatment.

A good example is the development of the intestines, salivary glands, and uterine organoids using ‘ATORM,’ an organoid culture platform. It addresses fundamental problems by overcoming limitations of existing regenerative treatments for certain difficult-to-treat diseases. It was certified as a high-tech product by the Ministry of Trade, Industry and Energy and chosen as an inter-ministerial regenerative medical technology development project proving its technological prowess.

Before the event, CEO Jongman Yoo said, “quick decision-making and higher chances of success are important when developing new a drug. I hope we would be able to provide information about the unique technology of Organoid Sciences at this webinar.”

Pangyo Technovalley is an innovation hub for global companies comparable to the Silicon Valley in the US, Zhongguancun in China, and STATION F in France. It is an Asia tech hub with 1,259 IT, BT, CT, and NT companies that possess innovative products and technologies. Located just south of the metropolitan area, it provides the best environment for Korean companies to do business with great transportation access and infrastructure.

Various high-tech companies are located in Pangyo Technovalley, and it is occupied by 64,000 full-time employees, many in their 20-30s. In terms of industry, the companies are engaged in information technology, contents technology, biotechnology, and nanotechnology.

With the support of innovative companies with global capabilities such as Kakao, Naver, AhnLab, Krafton, NCSoft, Nexon, and Hancom, companies in Pangyo Technovalley recorded 107 trillion won in sales last year. Investment and infrastructure growth in Pangyo is expected to continue, with the Metaverse hub entering Pangyo this year.

Source: Pangyo Techno Valley Official Newsroom